D
Bright Minds Biosciences Inc.
DRUG · NASDAQ · Healthcare · 748M
Closing price
$54.05
+3.94% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.5×
Enterprise value / EBITDAEV/EBITDA
-35.8×
Free cash flow yieldFCF yield
-1.7%
Return on equityROE
-14.9%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
6.8×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.